Clinical Trial Update: Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort

View source ↗

Summary

This clinical trial studied the stability of anti-glycan antibodies in a Saint-Etienne inflammatory bowel disease cohort and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Crohn's Disease, Ulcerative Colitis | Status: COMPLETED